Literature DB >> 28228492

Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains.

W Demczuk1, S Sidhu1, M Unemo2, D M Whiley3, V G Allen4, J R Dillon5, M Cole6, C Seah4, E Trembizki3, D L Trees7, E N Kersh7, A J Abrams7, H J C de Vries8,9,10, A P van Dam11,12, I Medina1, A Bharat1, M R Mulvey1, G Van Domselaar1, I Martin13.   

Abstract

A curated Web-based user-friendly sequence typing tool based on antimicrobial resistance determinants in Neisseria gonorrhoeae was developed and is publicly accessible (https://ngstar.canada.ca). The N. gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) molecular typing scheme uses the DNA sequences of 7 genes (penA, mtrR, porB, ponA, gyrA, parC, and 23S rRNA) associated with resistance to β-lactam antimicrobials, macrolides, or fluoroquinolones. NG-STAR uses the entire penA sequence, combining the historical nomenclature for penA types I to XXXVIII with novel nucleotide sequence designations; the full mtrR sequence and a portion of its promoter region; portions of ponA, porB, gyrA, and parC; and 23S rRNA sequences. NG-STAR grouped 768 isolates into 139 sequence types (STs) (n = 660) consisting of 29 clonal complexes (CCs) having a maximum of a single-locus variation, and 76 NG-STAR STs (n = 109) were identified as unrelated singletons. NG-STAR had a high Simpson's diversity index value of 96.5% (95% confidence interval [CI] = 0.959 to 0.969). The most common STs were NG-STAR ST-90 (n = 100; 13.0%), ST-42 and ST-91 (n = 45; 5.9%), ST-64 (n = 44; 5.72%), and ST-139 (n = 42; 5.5%). Decreased susceptibility to azithromycin was associated with NG-STAR ST-58, ST-61, ST-64, ST-79, ST-91, and ST-139 (n = 156; 92.3%); decreased susceptibility to cephalosporins was associated with NG-STAR ST-90, ST-91, and ST-97 (n = 162; 94.2%); and ciprofloxacin resistance was associated with NG-STAR ST-26, ST-90, ST-91, ST-97, ST-150, and ST-158 (n = 196; 98.0%). All isolates of NG-STAR ST-42, ST-43, ST-63, ST-81, and ST-160 (n = 106) were susceptible to all four antimicrobials. The standardization of nomenclature associated with antimicrobial resistance determinants through an internationally available database will facilitate the monitoring of the global dissemination of antimicrobial-resistant N. gonorrhoeae strains. © Crown copyright 2017.

Entities:  

Keywords:  Neisseria gonorrhoeae; antimicrobial resistance; molecular epidemiology; sequence typing

Mesh:

Substances:

Year:  2017        PMID: 28228492      PMCID: PMC5405263          DOI: 10.1128/JCM.00100-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.

Authors:  Lai-King Ng; Pamela Sawatzky; Irene E Martin; Stephanie Booth
Journal:  Sex Transm Dis       Date:  2002-12       Impact factor: 2.830

2.  Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

Authors:  C A Ison; J Hussey; K N Sankar; J Evans; S Alexander
Journal:  Euro Surveill       Date:  2011-04-07

3.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

4.  Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.

Authors:  Vanessa G Allen; Leo Mitterni; Christine Seah; Anuradha Rebbapragada; Irene E Martin; Colin Lee; Heather Siebert; Lynn Towns; Roberto G Melano; Donald E Low
Journal:  JAMA       Date:  2013-01-09       Impact factor: 56.272

5.  Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.

Authors:  David A Lewis; Charlotte Sriruttan; Etienne E Müller; Daniel Golparian; Lindy Gumede; Donald Fick; Johan de Wet; Venessa Maseko; Jennifer Coetzee; Magnus Unemo
Journal:  J Antimicrob Chemother       Date:  2013-02-14       Impact factor: 5.790

6.  High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Authors:  Magnus Unemo; Daniel Golparian; Robert Nicholas; Makoto Ohnishi; Anne Gallay; Patrice Sednaoui
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

7.  Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness.

Authors:  Douglas M Warner; William M Shafer; Ann E Jerse
Journal:  Mol Microbiol       Date:  2008-08-27       Impact factor: 3.501

8.  Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014.

Authors:  Walter Demczuk; Irene Martin; Shelley Peterson; Amrita Bharat; Gary Van Domselaar; Morag Graham; Brigitte Lefebvre; Vanessa Allen; Linda Hoang; Greg Tyrrell; Greg Horsman; John Wylie; David Haldane; Chris Archibald; Tom Wong; Magnus Unemo; Michael R Mulvey
Journal:  J Clin Microbiol       Date:  2016-03-02       Impact factor: 5.948

9.  PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods.

Authors:  Alexandre P Francisco; Cátia Vaz; Pedro T Monteiro; José Melo-Cristino; Mário Ramirez; Joäo A Carriço
Journal:  BMC Bioinformatics       Date:  2012-05-08       Impact factor: 3.169

10.  Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance.

Authors:  Michelle J Cole; Gianfranco Spiteri; Susanne Jacobsson; Rachel Pitt; Vlad Grigorjev; Magnus Unemo
Journal:  BMC Infect Dis       Date:  2015-08-11       Impact factor: 3.090

View more
  51 in total

1.  First Case of Ceftriaxone-Resistant Multidrug-Resistant Neisseria gonorrhoeae in Singapore.

Authors:  Karrie Kwan Ki Ko; Martin T W Chio; Sui Sin Goh; Ai Ling Tan; Tse Hsien Koh; Nurdyana Binte Abdul Rahman
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Genomic Analysis Reveals Antibiotic-Susceptible Clones and Emerging Resistance in Neisseria gonorrhoeae in Saskatchewan, Canada.

Authors:  Nidhi R Parmar; Reema Singh; Irene Martin; Sumudu R Perera; Walter Demczuk; Anthony Kusalik; Jessica Minion; Jo-Anne R Dillon
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

Review 3.  Applications of genomics to slow the spread of multidrug-resistant Neisseria gonorrhoeae.

Authors:  Tatum D Mortimer; Yonatan H Grad
Journal:  Ann N Y Acad Sci       Date:  2018-06-06       Impact factor: 5.691

Review 4.  World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.

Authors:  Magnus Unemo; Monica M Lahra; Michelle Cole; Patricia Galarza; Francis Ndowa; Irene Martin; Jo-Anne R Dillon; Pilar Ramon-Pardo; Gail Bolan; Teodora Wi
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706

5.  Typing of Neisseria Gonorrhoeae isolates in Shenzhen, China from 2014-2018 reveals the shift of genotypes associated with antimicrobial resistance.

Authors:  Yizhun Li; Yamei Li; Leshan Xiu; Yaling Zeng; Chi Zhang; Liying Sun; LuLu Zhang; Feng Wang; Junping Peng
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.191

6.  Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in Johannesburg, South Africa.

Authors:  Liteboho D Maduna; Marleen M Kock; Brian M J W van der Veer; Oscar Radebe; James McIntyre; Lieke B van Alphen; Remco P H Peters
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

7.  Antibiotic Treatment Regimes as a Driver of the Global Population Dynamics of a Major Gonorrhea Lineage.

Authors:  Magnus N Osnes; Lucy van Dorp; Ola B Brynildsrud; Kristian Alfsnes; Thamarai Schneiders; Kate E Templeton; Koji Yahara; Francois Balloux; Dominique A Caugant; Vegard Eldholm
Journal:  Mol Biol Evol       Date:  2021-04-13       Impact factor: 16.240

Review 8.  Establishing Novel Molecular Algorithms to Predict Decreased Susceptibility to Ceftriaxone in Neisseria gonorrhoeae Strains.

Authors:  Eric Y Lin; Paul C Adamson; Xiaomeng Deng; Jeffrey D Klausner
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

9.  Antimicrobial Resistance Mechanisms, Multilocus Sequence Typing, and NG-STAR Sequence Types of Diverse Neisseria gonorrhoeae Isolates in KwaZulu-Natal, South Africa.

Authors:  Nireshni Mitchev; Ravesh Singh; Mushal Allam; Stanford Kwenda; Arshad Ismail; Nigel Garrett; Veron Ramsuran; Abraham J Niehaus; Koleka P Mlisana
Journal:  Antimicrob Agents Chemother       Date:  2021-07-19       Impact factor: 5.191

10.  Sudden emergence of a Neisseria gonorrhoeae clade with reduced susceptibility to extended-spectrum cephalosporins, Norway.

Authors:  Magnus N Osnes; Xavier Didelot; Jolinda de Korne-Elenbaas; Kristian Alfsnes; Ola B Brynildsrud; Gaute Syversen; Øivind Jul Nilsen; Birgitte Freiesleben De Blasio; Dominique A Caugant; Vegard Eldholm
Journal:  Microb Genom       Date:  2020-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.